Home
Blue Owl Capital Holdings reported a 9.99% stake in Marker Therapeutics MRKR · 1,127,052 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.99%
- Last report
- 5.18% · filed 25/02/14
- Shares held
- 1,127,052 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 25/03/31
- Filed
- 25/05/15
9.99% stake · +4.8pp from the last report
- Stake
- 9.99%
- Last report
- 5.18%
- Since last report
- +4.8pp
Marker Therapeutics trades, last 26 weeks
What else happened in Marker Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Blue Owl Capital Holdings's other 5% stake reports
- Blue Owl Capital Holdings
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.19% stake
2,934,015 sh
3.19% stake
Filed 08/12
- Blue Owl Capital Holdings
5% stakeAktis Oncology
5% stakeAktis Oncology
AKTS
5.92% stake
3,161,348 sh
5.92% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.54% stake
5,089,015 sh
5.54% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeImageneBio
5% stakeImageneBio
IMA
8.51% stake
959,337 sh
8.51% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeFinance of America Companies
5% stakeFinance of America Companies
FOA
9.49% stake
827,409 sh
9.49% stake
Filed 02/12
